🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The proposed study will consist of a 5-week double-blind cross-over study t...
Status
Completed
Location
University of Chicago
Start Date
2018-03-20
Trial ID
NCT03348930
Treatments Being Tested
The experimental design is an open-label two-week trial of tolcapone to eva...
Status
Unknown
Location
Sheppard Pratt Health System
Start Date
2015-11
Trial ID
NCT02652598
Treatments Being Tested
In this study, we seek to understand the effects of tolcapone, an FDA-appro...
Status
Completed
Location
University of California, Berkeley
Start Date
2010-03
Trial ID
NCT01158950
The goal of the proposed study is to evaluate the efficacy and safety of to...
Status
Completed
Location
Ambulatory Research Center
Start Date
2009-06
Trial ID
NCT00927563
Treatments Being Tested
The investigators will perform single-dose pharmacokinetic (PK) studies in ...
Status
Completed
Location
Robert Wood Johnson University Hospital Somerset
Start Date
2022-02-01
Trial ID
NCT05065671
Treatments Being Tested
In this study, pharmacologic effects of COMT inhibition during sleep depriv...
Status
Completed
Location
University of Zurich, Institute of Pharmacology and Toxicology
Start Date
2013-06
Trial ID
NCT02080715
This study will test the hypothesis that a medication called tolcapone (Bra...
Status
Completed
Location
University of Pennsylvania
Start Date
2010-01
Trial ID
NCT01001520
The ability to regulate impulses enables us to plan for the future, to main...
Status
Completed
Location
VA Northern California Health Care System, Mather, CA
Start Date
2015-08-01
Trial ID
NCT02260570
The goals of this within-subject pilot study are: (1) assess the feasibilit...
Status
Completed
Location
University of Pennsylvania
Start Date
2008-07
Trial ID
NCT01202955
Clinical proof of concept study to evaluate SOM0226 efficacy in TTR Amyloid...
Status
Completed
Location
Hospital Vall d'Hebron
Start Date
2014-07
Trial ID
NCT02191826
Treatments Being Tested